Display Settings:

Format

Send to:

Choose Destination
    J Craniofac Surg. 2008 Nov;19(6):1613-7.

    Lower facial contouring with botulinum toxin type A.

    Source

    Department of Head and Neck Pathology, Oral Cavity and Audio-Verbal Communication, 2nd University of Naples, Naples, Italy.

    Abstract

    The use of botulinum toxin (BoNT) is well established in medical practice. The application of BoNT extends over many indications such as strabismus, blepharospasm, hemifacial spasm, and others. Another indication for the use of BoNT type A is the masseteric muscle hypertrophy to obtain a lower facial contouring. Authors report the treatment of 5 patients with intramuscular injection of BoNT. A high degree of patient and physician satisfaction was noted after the treatment. Authors concluded that BoNT type A can safely be considered as a noninvasive drug treatment for patients with MMH.

    PMID:
    19098563
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk